Trulieve Cannabis Corp., a leading U.S. medical cannabis company, will release its third quarter 2026 financial results on November 5, 2026. The company's CEO Kim Rivers and CFO Jan Reese will discuss the financial and operating results in a conference call at 8:30 AM Eastern Time. Investors and interested parties can join via phone or webcast. This earnings report will provide insight into Trulieve's performance and growth prospects in the expanding cannabis market.
Trulieve Cannabis Corp.'s upcoming Q3 2026 results conference call is noted alongside Pluang's Health-sector market snapshot as of Oct 06, 2026 18:43 WIB: out of 100 priced US Health stocks, 68 rose and 24 fell today. Notable movers include TXG at USD 100.40 with a 1-day change of +2.72% and a typical hold time on Pluang of 93 days, TWST at USD 210.32 up +2.60% with 92% sell order activity, and CRSP at USD 58.81 up +2.56% with a typical hold time of 77 days.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
